However, ZEB2 expression was higher in acute myeloid leukemia (LAML), brain lower grade glioma (LGG), pancreatic adenocarcinoma (PAAD), and skin cutaneous melanoma (SKCM) than in normal tissue (Figure 1). This evidence concerns the gene ZEB2 and pancreatic adenocarcinoma.